ZEB2 has been shown to enhance the invasion and metastasis of a variety of malignant tumors including colorectal cancer 23, gastric cancer 24, breast cancer 25, bladder cancer 26, and nasopharyngeal carcinoma 27. Here, ZEB2 is linked to gastric cancer.